FFA
AZN icon

Fragasso Financial Advisors’s AstraZeneca AZN Stock Holding History

Fragasso Financial Advisors’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-8,783
Closed -$1.23M – 287
2025
Q2 		$1.23M Sell
8,783
-213
-2% -$29.9K 0.08% 114
2025
Q1 		$1.32M Buy
8,996
+18
+0.2% +$2.6K 0.1% 104
2024
Q4 		$1.18M Buy
8,978
+21
+0.2% +$2.94K 0.09% 105
2024
Q3 		$1.4M Buy
8,957
+62
+0.7% +$10K 0.11% 99
2024
Q2 		$1.39M Buy
8,895
+51
+0.6% +$7.67K 0.11% 98
2024
Q1 		$1.2M Buy
8,844
+59
+0.7% +$7.81K 0.1% 102
2023
Q4 		$1.18M Sell
8,785
-106
-1% -$13.8K 0.11% 102
2023
Q3 		$1.2M Buy
8,891
+29
+0.3% +$3.96K 0.13% 96
2023
Q2 		$1.27M Buy
8,862
+34
+0.4% +$5K 0.14% 98
2023
Q1 		$1.23M Buy
8,828
+245
+3% +$33K 0.14% 83
2022
Q4 		$1.16M Buy
8,583
+14
+0.2% +$1.76K 0.14% 87
2022
Q3 		$940K Hold
8,569
– – 0.13% 80
2022
Q2 		$1.13M Hold
8,569
– – 0.15% 73
2022
Q1 		$1.14M Buy
8,569
+22
+0.3% +$2.64K 0.13% 74
2021
Q4 		$996K Sell
8,547
-7
-0.1% -$824 0.12% 78
2021
Q3 		$1.03M Buy
+8,554
New +$996K 0.14% 73

Other funds holding AZN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Fragasso Financial Advisors's AZN Position: Q3 2025 in Review

Fragasso Financial Advisors sold out of AstraZeneca (AZN) in Q3 2025, closing a stake of 8,783 shares — an estimated $1.23M sold.

Fragasso Financial Advisors first reported a position in AZN in Q3 2021 and held it in 16 quarters. The position peaked at $1.4M in Q3 2024. 1,288 funds tracked by Wall St. Rank hold AZN as of Q3 2025.

  • Fragasso Financial Advisors reported no remaining AstraZeneca position as of Q3 2025 after selling out during the quarter.
  • Fragasso Financial Advisors sold 8,783 AstraZeneca shares in Q3 2025, an estimated $1.23M.
  • Fragasso Financial Advisors first reported a position in AstraZeneca in Q3 2021 and held it in 16 quarters.
  • Fragasso Financial Advisors's AstraZeneca position peaked at $1.4M in Q3 2024.
  • 1,288 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2025.

Based on Fragasso Financial Advisors's 13F filing for Q3 2025, filed 6 Oct 2025.